These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 27995466)
41. Naproxen Microparticulate Systems Prepared Using In Situ Crystallisation and Freeze-Drying Techniques. Solaiman A; Tatari AK; Elkordy AA AAPS PharmSciTech; 2017 Jul; 18(5):1438-1446. PubMed ID: 28004343 [TBL] [Abstract][Full Text] [Related]
42. Improvement in oral bioavailability and dissolution of tanshinone IIA by preparation of solid dispersions with porous silica. Yan HM; Sun E; Cui L; Jia XB; Jin X J Pharm Pharmacol; 2015 Sep; 67(9):1207-14. PubMed ID: 25944009 [TBL] [Abstract][Full Text] [Related]
43. Formulation of nimodipine nanocrystals for oral administration. Li J; Fu Q; Liu X; Li M; Wang Y Arch Pharm Res; 2016 Feb; 39(2):202-212. PubMed ID: 26584914 [TBL] [Abstract][Full Text] [Related]
44. Enhancement of Oral Bioavailability of Curcumin by a Novel Solid Dispersion System. Hu L; Shi Y; Li JH; Gao N; Ji J; Niu F; Chen Q; Yang X; Wang S AAPS PharmSciTech; 2015 Dec; 16(6):1327-34. PubMed ID: 25804949 [TBL] [Abstract][Full Text] [Related]
45. Preparation and characterization of betulin nanoparticles for oral hypoglycemic drug by antisolvent precipitation. Zhao X; Wang W; Zu Y; Zhang Y; Li Y; Sun W; Shan C; Ge Y Drug Deliv; 2014 Sep; 21(6):467-79. PubMed ID: 24479653 [TBL] [Abstract][Full Text] [Related]
46. Fabrication of Ibrutinib Nanosuspension by Quality by Design Approach: Intended for Enhanced Oral Bioavailability and Diminished Fast Fed Variability. Rangaraj N; Pailla SR; Chowta P; Sampathi S AAPS PharmSciTech; 2019 Oct; 20(8):326. PubMed ID: 31659558 [TBL] [Abstract][Full Text] [Related]
47. Improved oral bioavailability of core-shell structured beads by redispersion of the shell-forming nanoparticles: preparation, characterization and in vivo studies. Yao Q; Tao X; Tian B; Tang Y; Shao Y; Kou L; Gou J; Li X; Yin T; Tang X Colloids Surf B Biointerfaces; 2014 Jan; 113():92-100. PubMed ID: 24060933 [TBL] [Abstract][Full Text] [Related]
48. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics. Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995 [TBL] [Abstract][Full Text] [Related]
49. In Vitro and In Vivo Evaluation of Olmesartan Medoxomil Microcrysta ls and Nanocrystals: Preparation, Characterization, and Pharmacokinet ic Comparison in Beagle Dogs. Chai R; Gao H; Ma Z; Guo M; Fu Q; Liu H; He Z Curr Drug Deliv; 2019; 16(6):500-510. PubMed ID: 31244438 [TBL] [Abstract][Full Text] [Related]
50. Preparation and Characterization of the Sulfobutylether-β-Cyclodextrin Inclusion Complex of Amiodarone Hydrochloride with Enhanced Oral Bioavailability in Fasted State. Wang D; Chen G; Ren L AAPS PharmSciTech; 2017 Jul; 18(5):1526-1535. PubMed ID: 27757923 [TBL] [Abstract][Full Text] [Related]
51. Bicalutamide nanocrystals with improved oral bioavailability: in vitro and in vivo evaluation. Pokharkar VB; Malhi T; Mandpe L Pharm Dev Technol; 2013; 18(3):660-6. PubMed ID: 22394215 [TBL] [Abstract][Full Text] [Related]
52. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP. Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357 [TBL] [Abstract][Full Text] [Related]
53. Investigation of salt formation between memantine and pamoic acid: Its exploitation in nanocrystalline form as long acting injection. Mittapelly N; Rachumallu R; Pandey G; Sharma S; Arya A; Bhatta RS; Mishra PR Eur J Pharm Biopharm; 2016 Apr; 101():62-71. PubMed ID: 26850817 [TBL] [Abstract][Full Text] [Related]
54. Rutin nanosuspension for potential management of osteoporosis: effect of particle size reduction on oral bioavailability, Gera S; Pooladanda V; Godugu C; Swamy Challa V; Wankar J; Dodoala S; Sampathi S Pharm Dev Technol; 2020 Oct; 25(8):971-988. PubMed ID: 32403972 [TBL] [Abstract][Full Text] [Related]
55. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension. Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534 [TBL] [Abstract][Full Text] [Related]
56. Design, Optimization, and Evaluation of Lurasidone Hydrochloride Nanocrystals. Shah S; Parmar B; Soniwala M; Chavda J AAPS PharmSciTech; 2016 Oct; 17(5):1150-8. PubMed ID: 26586537 [TBL] [Abstract][Full Text] [Related]
57. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation. Dudhipala N; Veerabrahma K Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287 [TBL] [Abstract][Full Text] [Related]
58. Oral bioavailability and pharmacodynamic activity of hesperetin nanocrystals generated using a novel bottom-up technology. Shete G; Pawar YB; Thanki K; Jain S; Bansal AK Mol Pharm; 2015 Apr; 12(4):1158-70. PubMed ID: 25785392 [TBL] [Abstract][Full Text] [Related]
59. Preparation, characterization and in vivo evaluation of amorphous tacrolimus nanosuspensions produced using CO2-assisted in situ nanoamorphization method. Wang Y; Han X; Wang J; Wang Y Int J Pharm; 2016 May; 505(1-2):35-41. PubMed ID: 27034003 [TBL] [Abstract][Full Text] [Related]
60. Preparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancement. Yun F; Kang A; Shan J; Zhao X; Bi X; Li J; Di L Int J Pharm; 2014 Apr; 465(1-2):436-43. PubMed ID: 24576810 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]